Nonclinical Services - Preclinical Services

Uncertainty is an inescapable part of any toxicology program. Data for decision making is wide ranging and complex, and decisions are routinely made on the basis of often incomplete information, therefore experienced toxicologists (general, DART and genetic) and pathologists (anatomic and clinical) working in close collaboration with other study scientists are essential in optimizing risk management decision making in the nonclinical safety assessment of any pharmaceutical, biopharmaceutical or medical device development program.

Toxicology

  • General toxicology
  • Genetic toxicology
  • Developmental and Reproductive toxicology (DART)

Pathology

  • Anatomic histopathology
  • Clinical pathology (clinical chemistry and hematology)

Early Drug Development

  • Support from late Discovery Phase

ADME

  • Drug metabolism
  • Pharmcokinetics
  • Toxicokinetics

Nonclinical Regulatory

  • Nonclinical regulatory documentation (CTD, IND)

Therapeutic Areas of Expertise

  • List of areas of expertise